» Articles » PMID: 15723735

Treatment Outcomes Among Women and Men Methamphetamine Abusers in California

Overview
Specialty Psychiatry
Date 2005 Feb 23
PMID 15723735
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

This prospective longitudinal study examined treatment outcomes among 1,073 methamphetamine-abusing patients (567 women, 506 men) from 32 community-based outpatient and residential programs in 13 California counties. Data were collected at intake and at 3 months and 9 months after admission. With one exception, improvements from baseline to follow-up were observed in all areas measured by the Addiction Severity Index for both women and men in either modality. Compared to men, women demonstrated greater improvement in family relationships and medical problems, and similar improvement in all other areas, despite the fact that more women were unemployed, had childcare responsibilities, were living with someone who also used alcohol or drugs, had been physically or sexually abused, and reported more psychiatric symptoms. Implications for service improvement are discussed.

Citing Articles

Gender Differences in the Effects of Trust on Substance Abuse Severity Among Incarcerated Stimulant Offenders in Japan.

Omiya S, Shimane T, Takagishi Y, Kondo A, Kobayashi M, Takahashi M Neuropsychopharmacol Rep. 2025; 45(1):e12517.

PMID: 39779998 PMC: 11711050. DOI: 10.1002/npr2.12517.


Neurobehavioral disorders among children born to mothers exposed to illicit substances during pregnancy.

Chen V, Lee C, Wu S, Gossop M BMC Med. 2024; 22(1):581.

PMID: 39696283 PMC: 11656950. DOI: 10.1186/s12916-024-03762-9.


Effects of systemic pretreatment with the NAALADase inhibitor 2-PMPA on oral methamphetamine reinforcement in C57BL/6J mice.

Fultz E, Nei A, Chi J, Lichter J, Szumlinski K Front Psychiatry. 2024; 15:1297275.

PMID: 38638417 PMC: 11024460. DOI: 10.3389/fpsyt.2024.1297275.


Modeling methamphetamine use disorder in mammals: Sex differences in behavioral, biochemical, and transcriptional consequences.

Daiwile A, Cadet J Adv Pharmacol. 2024; 99:145-168.

PMID: 38467480 PMC: 11474929. DOI: 10.1016/bs.apha.2023.08.002.


Neuropharmacological Evidence Implicating Drug-Induced Glutamate Receptor Dysfunction in Affective and Cognitive Sequelae of Subchronic Methamphetamine Self-Administration in Mice.

Denning C, Madory L, Herbert J, Cabrera R, Szumlinski K Int J Mol Sci. 2024; 25(3).

PMID: 38339206 PMC: 10856401. DOI: 10.3390/ijms25031928.